Join our daily newsletter At The Bell to receive exclusive market insights
RocketDNA (ASX:RKT) has sent off its first ‘xBot’ autonomous mine asset inspection autonomous drone package to the Congo’s Kamoa Copper.
The first of its xBot products to be sent off for mines across the seas, RocketDNA’s tech will help the company specifically perform critical inspections on chimney stacks, rooftops, and conveyer belts and smelters.
However, shares in the microcap dipped -7% on Tuesday morning to 1.3cps – perhaps because the value of the contract is only US$62,000.
This comes in well below the drone company’s recent $300,000 contract to provide a ‘patrolbot‘ to another similar client, with that product of the company’s being an earthbound equivalent to the xBot drone.
This was backed up by comments in the relevant HotCopper announcement thread on Tuesday.
“I would’ve hoped that we’d be charging a smidge more for such a great product and service,” user Nickynoonah wrote.
“$62k isn’t even worth announcing. Barely covers one directors fee for 12 months,” another user – Burge13 – wrote in kind.
At least one user was more optimistic on the sale shoring up the path to higher-valued future contracts – and to be fair, the nature of the deal will probably have some eyes on Kamoa, especially if RocketDNA can do what its truly trying to do – cut down on labour costs for inspections.
While the company goes on a lot about AI on its website, that’s the ultimate value proposition, here.
“Our xBot technology is purpose-built for challenging environments like mining … this first deployment in the DRC underscores our commitment to supporting enterprise customers with cutting-edge technology,” RocketDNA CEO Christopher Clark said.
RKT last traded at 1.3cps.
Join the discussion: See what HotCopper users are saying about RocketDNA and be part of the conversations that move the markets.
The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.
